Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Landray

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
The Lancet. Gastroenterology & Hepatology|January 17, 2021
Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based studyEva J A Morris, Raphael Goldacre, Enti Spata, et al.
Journal of Clinical and Translational Science|December 10, 2024
Accelerating evidence generation: Addressing critical challenges and charting a path forwardJeeyon G Rim, Jennifer G Jackman, Christoph P Hornik, et al.
European Heart Journal|June 17, 2015
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of CardiologyNeville Jackson, Dan Atar, Maria Borentain, et al.
Scientific Data|April 13, 2019
Physical activity, sleep and cardiovascular health data for 50,000 individuals from the MyHeart Counts StudySteven G Hershman, Brian M Bot, Anna Shcherbina, et al.
American Heart Journal|May 25, 2024
Framework of the strengths and challenges of clinically integrated trials: An expert panel reportAnthony E Peters, W Schuyler Jones, Brian Anderson, et al.
The Lancet. Diabetes & Endocrinology|September 9, 2024
Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trialsClaire Vale, Peter J Godolphin, David Fisher, et al.
Transplantation Research|May 7, 2013
Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocolRichard Haynes, Colin Baigent, Paul Harden, et al.
BMJ Open|June 17, 2021
Realising the full potential of data-enabled trials in the UK: a call for actionMatthew R Sydes, Yolanda Barbachano, Louise Bowman, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
The Lancet. Gastroenterology & Hepatology|January 17, 2021
Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based studyEva J A Morris, Raphael Goldacre, Enti Spata, et al.
Journal of Clinical and Translational Science|December 10, 2024
Accelerating evidence generation: Addressing critical challenges and charting a path forwardJeeyon G Rim, Jennifer G Jackman, Christoph P Hornik, et al.
European Heart Journal|June 17, 2015
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of CardiologyNeville Jackson, Dan Atar, Maria Borentain, et al.
Scientific Data|April 13, 2019
Physical activity, sleep and cardiovascular health data for 50,000 individuals from the MyHeart Counts StudySteven G Hershman, Brian M Bot, Anna Shcherbina, et al.
American Heart Journal|May 25, 2024
Framework of the strengths and challenges of clinically integrated trials: An expert panel reportAnthony E Peters, W Schuyler Jones, Brian Anderson, et al.
The Lancet. Diabetes & Endocrinology|September 9, 2024
Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trialsClaire Vale, Peter J Godolphin, David Fisher, et al.
Transplantation Research|May 7, 2013
Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocolRichard Haynes, Colin Baigent, Paul Harden, et al.
BMJ Open|June 17, 2021
Realising the full potential of data-enabled trials in the UK: a call for actionMatthew R Sydes, Yolanda Barbachano, Louise Bowman, et al.
Pageof 5